Filtros de búsqueda

Lista de obras de Jonathan L. Halperin

"Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents

artículo científico publicado en 2008

2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina

article

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

artículo científico publicado en 2007

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

article

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

scientific article published on 13 December 2007

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to

artículo científico publicado en 2007

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2008

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2010

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)

article

2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline)

article

2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline).

artículo científico publicado en 2011

2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

artículo científico publicado en 2011

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

article

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

article by L. Samuel Wann et al published January 2011 in Journal of the American College of Cardiology

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

artículo científico publicado en 2011

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

article by Valentín Fuster Carulla et al published 15 March 2011 in Circulation

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2010

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

artículo científico publicado en 2011

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary

article

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary

artículo científico publicado en 2011

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American

artículo científico publicado en 2011

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American

artículo científico publicado en 2011

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American

artículo científico publicado en 2011

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2012

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2014

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2012

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2013

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society

artículo científico publicado en 2013

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2014

2016 ACC Lifelong Learning Competencies for General Cardiologists: A Report of the ACC Competency Management Committee

artículo científico publicado en 2016

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

article

A Baby in the Bathwater: Preserving Evidence-Based Medicine

artículo científico publicado en 2016

A pharmacogenetic versus a clinical algorithm for warfarin dosing

artículo científico publicado en 2013

A proposal for new clinical concepts in the management of atrial fibrillation

artículo científico

ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article

ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary

artículo científico publicado en 2004

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

artículo científico publicado en 2005

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article

ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

artículo científico publicado en 2006

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

artículo científico publicado en 2006

ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy

article

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

article

ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary

article

ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice G

artículo científico publicado en 2006

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

artículo científico publicado en 2007

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

article

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

article

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

scholarly article by Lee A. Fleisher et al published March 2008 in Anesthesia & Analgesia

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to R

artículo científico publicado en 2007

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

artículo científico publicado en 2007

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Gui

artículo científico publicado en 2007

ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Managemen

artículo científico publicado en 2008

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

article published 3 August 2004 in Circulation

ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, S

artículo científico publicado en 2006

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

artículo científico publicado en 2004

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

artículo científico publicado en 2004

ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation

article

ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writi

artículo científico publicado en 2004

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

article by Valentin Fuster et al published August 2006 in Journal of the American College of Cardiology

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European S

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

artículo científico publicado en 2007

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

scientific article published on 01 September 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiolog

artículo científico publicado en 2007

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

article

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

artículo científico publicado en 2008

ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the P

artículo científico publicado en 2008

ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the P

artículo científico publicado en 2008

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

article

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

article published 3 January 2006 in Circulation

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

article by Sidney C Smith et al published January 2006 in Journal of the American College of Cardiology

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001

article published in 2005

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2012

ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical C

artículo científico publicado en 2013

AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human

artículo científico

Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality

artículo científico publicado en 2003

Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force

artículo científico publicado en 2006

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

artículo científico publicado en 2015

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

article by Jack Hirsh et al published April 2003 in Circulation

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy

artículo científico publicado en 2003

Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice

artículo científico publicado en 2010

Anticoagulation for atrial fibrillation in the elderly

artículo científico publicado en 2005

Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.

artículo científico publicado en 2006

Anticoagulation in women with nonvalvular atrial fibrillation: insights from clinical trials.

artículo científico publicado en 2007

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.

artículo científico publicado en 2015

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Antithrombotic therapy for patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention: a review

artículo científico

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

artículo científico publicado en 2004

Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor

artículo científico publicado en 2004

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

artículo científico publicado en 2008

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I c

artículo científico publicado en 2016

Aortic regurgitation: disease progression and management

artículo científico publicado en 2008

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.

artículo científico publicado en 2018

Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial

artículo científico publicado en 2016

Aspirin in the Prevention of Coronary Disease

Association between troponin I levels and mortality in stable hemodialysis patients

artículo científico publicado en 2003

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

artículo científico publicado en 2010

Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis

artículo científico publicado en 2012

Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy

artículo científico publicado en 2004

Atrial Fibrillation — Risk Marker for Stroke

Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).

artículo científico publicado en 2015

Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis).

artículo científico publicado en 2010

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation

article

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience

artículo científico publicado en 2015

COCATS 4 Introduction

COCATS 4 Task Force 1: Training in Ambulatory, Consultative, and Longitudinal Cardiovascular Care

artículo científico

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing

artículo científico publicado en 2009

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

artículo científico publicado en 2016

Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.

artículo científico publicado en 2012

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

artículo científico publicado en 2016

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

artículo científico publicado en 2016

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

article

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

artículo científico publicado en 2014

Combining carotid endarterectomy with coronary bypass surgery: is it worth the risk?

artículo científico publicado en 2005

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

artículo científico publicado en 2010

Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies

artículo científico publicado en 2007

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?

artículo científico publicado en 2014

Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation

artículo científico publicado en 2014

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

artículo científico publicado en 2011

Current strategies in the evaluation and management of cocaine-induced chest pain

artículo científico

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

artículo científico publicado en 2013

Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).

artículo científico publicado en 2016

Device-detected atrial fibrillation: what to do with asymptomatic patients?

artículo científico publicado en 2015

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

artículo científico publicado en 2015

Do current guidelines result in overuse of warfarin anticoagulation in patients with atrial fibrillation?

artículo científico publicado en 2009

Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions

artículo científico publicado en 2017

Dronedarone in High-Risk Permanent Atrial Fibrillation

artículo científico publicado en 2011

Early management of atrial fibrillation to prevent cardiovascular complications

artículo científico

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.

artículo científico publicado en 2017

Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.

artículo científico publicado en 2018

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

artículo científico publicado en 2017

Efficacy and Safety of Rivaroxaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation and a History of Cancer: Observations from ROCKET AF

article by Sean T Chen et al published 14 September 2018 in European heart journal. Quality of care & clinical outcomes

Efficacy and safety of amiodarone in patients with atrial fibrillation in the era of target-specific anticoagulants.

artículo científico publicado en 2014

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Em

artículo científico publicado en 2014

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

artículo científico publicado en 2013

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

artículo científico

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

artículo científico

Elevated homocysteine levels in patients with end-stage renal disease.

artículo científico publicado en 2005

Embracing a new paradigm to sustain vascular medicine

artículo científico publicado en 2003

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

artículo científico publicado en 2013

Evaluation of patients with peripheral vascular disease

artículo científico publicado en 2002

Everything counts in large amounts: device-detected atrial high-rate arrhythmias.

artículo científico publicado en 2009

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

artículo científico publicado en 2015

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

artículo científico publicado en 2013

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences

artículo científico

Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.

artículo científico publicado en 2015

Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: the GLORIA-AF Registry Program.

artículo científico publicado en 2018

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

artículo científico publicado en 2013

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke...

artículo científico publicado en 2006

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci

artículo científico publicado en 2006

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

artículo científico publicado en 2011

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

artículo científico publicado en 2014

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF

artículo científico publicado en 2016

Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort

artículo científico publicado en 2010

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

artículo científico publicado en 2013

Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF

article by Sean T. Chen et al published June 2018 in American Heart Journal

Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model ⬇️

artículo científico publicado el 10 de noviembre de 2010

Improving stroke risk stratification in atrial fibrillation

scientific article published on June 2010

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study

artículo científico publicado en 2017

Ineligibility for anticoagulation in patients with atrial fibrillation

artículo científico

Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai

artículo científico publicado en 2017

Interaction between digoxin and dronedarone in the PALLAS trial

artículo científico publicado en 2014

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

scientific article published on 15 October 2013

Left Ventricular Thrombi and Cerebral Embolism

Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges

artículo científico publicado en 2007

Lessons from the Stroke Prevention in Atrial Fibrillation trials

artículo científico publicado en 2003

Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease

artículo científico publicado en 2006

Low intraoperative heart rate volatility is associated with early postoperative mortality in general surgical patients: a retrospective case-control study

artículo científico publicado en 2015

Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?

artículo científico publicado en 2012

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

artículo científico publicado en 2013

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines

artículo científico publicado en 2013

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

artículo científico publicado en 2013

Meeting the challenge of peripheral arterial disease

artículo científico publicado en 2003

Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT

artículo científico publicado en 2009

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

artículo científico publicado en 2016

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

artículo científico publicado en 2018

New anticoagulants for prevention of stroke in patients with atrial fibrillation

artículo científico publicado en 2011

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

artículo científico publicado en 2017

Novel antiplatelet and anticoagulant agents in the cardiac care unit

artículo científico

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation

artículo científico publicado en 2013

Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials

artículo científico publicado en 2014

OCT-based diagnosis and management of STEMI associated with intact fibrous cap.

artículo científico publicado en 2013

Objective quality assessment of atrial fibrillation ablation: a novel scoring system

artículo científico publicado en 2013

Obliteration of the left atrial appendage for prevention of thromboembolism

artículo científico publicado en 2003

Oral anticoagulants in the management of venous thromboembolism

artículo científico

Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial i

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

artículo científico publicado en 2013

Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy

artículo científico publicado en 2014

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

artículo científico publicado en 2013

Patent foramen ovale and recurrent stroke: another paradoxical twist

artículo científico publicado en 2002

Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease

artículo científico publicado en 2007

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial

artículo científico publicado en 2013

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial

artículo científico publicado en 2014

Peripheral pulmonary artery stenosis masquerading as pulmonary hypertension: A diagnostic and therapeutic challenge

Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation

artículo científico publicado en 2017

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

artículo científico

Postgraduate training in vascular medicine: proposed requirements and standards.

artículo científico publicado en 2003

Presidential address. Vascular medicine and biology: an evolving infrastructure

artículo científico publicado en 2002

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

artículo científico publicado en 2016

Prevention of stroke in patients with atrial fibrillation

artículo científico publicado en 2005

Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options

artículo científico publicado en 2012

Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.

artículo científico publicado en 2008

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices

artículo científico

Rate or rhythm control for atrial fibrillation: update and controversies

artículo científico publicado en 2012

Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients

artículo científico publicado en 2013

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

artículo científico publicado en 2016

Recurrent orthostatic global amnesia in a patient with postoperative hyperfibrinogenemia

artículo científico publicado en 2008

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

artículo científico

Reply

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

artículo científico publicado en 2016

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Fac

article by Jonathan P Piccini et al published 10 September 2013 in Circulation

Response to Letter Regarding Article, “Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)”

Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis

artículo científico publicado en 2013

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

artículo científico publicado en 2006

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

artículo científico publicado en 2012

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

artículo científico publicado en 2018

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

artículo científico

Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum

artículo científico publicado en 2016

Should we use anticoagulation for patients with chronic heart failure?

scientific article published on 01 November 2006

Standards and Barriers in Acute Stroke Therapy: A Leap Forward in the Evolution of Endovascular Interventions for Stroke.

artículo científico publicado en 2015

Stroke Prevention in the High-risk Atrial Fibrillation Patient: Medical Management ⬇️

artículo científico publicado el 1 de febrero de 2011

Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA-AF registry program.

artículo científico publicado en 2018

Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy

artículo científico publicado en 2016

Taking TASC to TASK: Evolving from nomenclature to guidelines

artículo científico publicado en 2015

Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: effect of diabetes

artículo científico publicado en 2016

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.

artículo científico publicado en 2017

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE

article

The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review

artículo científico publicado en 2017

The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico

The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines

artículo científico publicado en 2014

Thoracic aortic aneurysm and dissection

artículo científico publicado en 2014

Thrombocytopenia during heparin therapy: a clinical conundrum

artículo científico publicado en 2008

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

artículo científico publicado en 2017

Trials and tribulations of noninferiority: the ximelagatran experience

artículo científico publicado en 2006

Trials of novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation

artículo científico publicado en 2014

Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.

artículo científico publicado en 2017

US Preventive Services Task Force recommendation statement regarding screening for peripheral artery disease with the ankle-brachial index: déjà vu all over again

artículo científico publicado en 2018

Unstable angina in a patient with anomalous origin of the left main coronary artery from the right sinus of Valsalva

artículo científico publicado en 2010

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

artículo científico publicado en 2008

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

artículo científico publicado en 2016

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.

artículo científico publicado en 2016

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

artículo científico publicado en 2014

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

artículo científico publicado en 2016

Vorapaxar, combination antiplatelet therapy, and stroke

artículo científico publicado en 2014

Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects

artículo científico publicado en 2013

What can ongoing clinical trials of anticoagulants demonstrate?

artículo científico publicado en 2009

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

artículo científico publicado en 2003

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

artículo científico publicado en 2005

Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation

artículo científico publicado en 2005

[Guidelines for the management of patients with atrial fibrillation. Executive summary]

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda